Welcome to Visible Genetics’ Investor Relations webpage.
Visible Genetics is a rapidly growing pharmacogenomics company with proprietary products; automated DNA sequencer systems, molecular diagnostics reagents and GeneKits™, and advanced software applications. VGI has been selling its products internationally for the past 4 years and is the leading company in the field. VGI’s products are used: to identify infectious organisms such as HIV, Hepatitis and other infectious diseases and to match donor and recipient for tissue or organ transplantation. All of VGI’s test are aimed at improving patient care while at the same time, reducing overall healthcare costs.
Visible Genetics went public in June 1996 and its stock is listed on the NASDAQ market under the symbol VGIN.